Ropes & Gray Earns Worldwide Rankings in Chambers Global 2022

Rankings & Awards
February 17, 2022

The 2022 edition of Chambers Global acknowledged Ropes & Gray as a leading international law firm in 48 categories across the Asia-Pacific, Europe, Latin America, and the United States, and recognized the firm’s lawyers with 63 individual rankings. The firm secured seven new practice rankings.

Global-wide

  • Banking & Finance
  • Corporate Investigations/Anti-Corruption
  • Investment Funds: Hedge Funds
  • Investment Funds: Private Equity: Fund Formation
  • Life Sciences
  • Private Equity

Asia-Pacific

  • Corporate/M&A: Private Equity
  • Intellectual Property
  • Investment Funds: Private Equity
  • Life Sciences

China

  • Banking & Finance: Leveraged & Acquisition Finance (International Firms)
  • Corporate Investigations/Anti-Corruption (International Firms)
  • Corporate/M&A: Highly Regarded (International Firms)
  • Intellectual Property (International Firms)
  • International & Cross-Border Transactions (International Firms)
  • Investment Funds: Private Equity (International Firms)

India

  • Corporate/M&A (International Firms)

Japan

  • Banking & Finance: International Firms
  • Corporate/M&A: International Firms

Latin America-wide

  • Corporate Investigations: International Firms

South Korea

  • Corporate/M&A: International Firms
  • Intellectual Property: International Firms
  • International & Cross-Border Transactions: International Firms

United Kingdom

  • Tax

USA

  • Banking & Finance
  • Bankruptcy/Restructuring: The Elite
  • Capital Markets: Equity: Issuer Representation
  • Capital Markets: Equity: Manager Representation
  • Competition/Antitrust
  • Corporate Crime & Investigations
  • Corporate/M&A (International & Cross-Border)
  • FCPA
  • Finance & Capital Markets (International & Cross-Border)
  • Hedge Funds
  • Investigations & Enforcement (International & Cross-Border)
  • Investment Funds & Asset Management (International & Cross-Border)
  • Investment Funds: Investor Representation
  • Investment Funds: Regulatory & Compliance
  • Life Sciences & Pharmaceutical Sector (International & Cross-Border)
  • Life Sciences: Regulatory/Compliance
  • Privacy & Data Security: The Elite
  • Private Equity: Buyouts: High-End Capability
  • Private Equity: Buyouts: Mid-Market
  • Private Equity: Fund Formation
  • Registered Funds
  • SPACs
  • Tax: Corporate & Finance